Bolden Therapeutics Funding & Investors
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.
boldentherapeutics.comTotal Amount Raised: $2,600,880
Bolden Therapeutics Funding Rounds
Grant
$406,466
Grant Investors
National Institute on Aging (NIA)Grant
$497,500
Grant Investors
National Institute on Aging (NIA)Pre Seed
$800,000
Pre Seed Investors
Partners ResoluteGrant
$896,914
Grant Investors
National Institute on Aging (NIA)
Funding info provided by Diffbot.